Simulations Plus Inc (SLP) Stock Analysis — PE Ratio, PS Ratio, Intrinsic Value & 2030 Price Target
Simulations Plus Inc stock (SLP) is currently trading at $11.54. Simulations Plus Inc PS ratio (Price-to-Sales) is 3.06. Analyst consensus price target for SLP is $24.67. WallStSmart rates SLP as Sell.
- SLP PE ratio analysis and historical PE chart
- SLP PS ratio (Price-to-Sales) history and trend
- SLP intrinsic value — DCF, Graham Number, EPV models
- SLP stock price prediction 2025 2026 2027 2028 2029 2030
- SLP fair value vs current price
- SLP insider transactions and insider buying
- Is SLP undervalued or overvalued?
- Simulations Plus Inc financial analysis — revenue, earnings, cash flow
- SLP Piotroski F-Score and Altman Z-Score
- SLP analyst price target and Smart Rating
Simulations Plus Inc
📊 No data available
Try selecting a different time range
Smart Analysis
Simulations Plus Inc (SLP) · 10 metrics scored
Smart Score
Category Performance
WallStSmart pulls financial metrics like revenue growth, profit margins, and valuation ratios and scores each one from 0 to 10 based on how strong or weak it is. Those 10 scores are grouped into 4 categories: Growth, Profitability, Valuation, and Quality — which form the 4 axes of the spider chart you see. The categories are then combined into a final score out of 100, but not equally. Growth and Profitability together count for 60% of the total, because a fast-growing profitable business matters more than just a cheap one. That final number maps to a rating (Strong Buy, Buy, Hold, Avoid) and a letter grade, giving you one clear Stock Rating.
Investment Thesis
Strong fundamentals in price/book, eps growth, institutional own.. Concerns around market cap and peg ratio. Mixed signals suggest waiting for clearer direction before acting.
Simulations Plus Inc (SLP) Key Strengths (3)
Earnings per share surging 200.00% year-over-year
85.17% of shares held by major funds and institutions
Trading at 1.85x book value, attractively priced
Supporting Valuation Data
Simulations Plus Inc (SLP) Areas to Watch (7)
Company is destroying shareholder value
Revenue declining -2.70%, a shrinking business
Company is losing money with a negative profit margin
Near-zero operating margins, business under pressure
Very expensive relative to growth, significant premium
Micro-cap company with very limited liquidity and high volatility
Revenue is fairly priced at 3.06x sales
Simulations Plus Inc (SLP) Detailed Analysis Report
Overall Assessment
This company scores 40/100 in our Smart Analysis, earning a D grade. Out of 10 metrics analyzed, 3 register as strengths (avg 9.3/10) while 7 fall into concern territory (avg 1.7/10). The category breakdown reveals uneven performance, with some areas requiring attention.
The Bull Case
The strongest argument centers on EPS Growth, Institutional Own., Price/Book. Valuation metrics including Price/Book (1.85) suggest the stock is attractively priced. Growth metrics are encouraging with EPS Growth at 200.00%.
The Bear Case
The primary concerns are Return on Equity, Revenue Growth, Profit Margin. Some valuation metrics including PEG Ratio (9.88), Price/Sales (3.06) suggest expensive pricing. Growth concerns include Revenue Growth at -2.70%, which may limit upside. Profitability pressure is visible in Return on Equity at -41.20%, Operating Margin at 3.87%, Profit Margin at -81.70%.
Key Dynamics to Monitor
Three factors to monitor going forward. First, whether Return on Equity improves, as this is the primary drag on the overall score. Second, margin trajectory, with Return on Equity at -41.20% needing improvement to support the investment thesis. Third, growth sustainability, with Revenue Growth at -2.70% needing to reaccelerate.
Risk Considerations
Based on the metric profile, this is a higher risk investment. There are more areas of concern than strength, warranting a more conservative position size. Investors should size positions according to their risk tolerance and maintain diversification.
Bottom Line
Fundamental challenges outweigh strengths at current levels. Return on Equity and Revenue Growth are the primary drags. Consider waiting for meaningful improvement before committing capital.
Disclaimer: Smart Analysis is a scoring system developed by WallStSmart Team. Scores update daily using multi-model valuation framework. Always conduct your own research and consult with financial advisors before making investment decisions.
SLP Price-to-Sales(PS) Ratio Chart
Historical valuation based on market cap ÷ trailing 12-month revenue
SLP's Price-to-Sales ratio of 3.06x trades at a deep discount to its historical average of 8.93x (7th percentile). The current valuation is 91% below its historical high of 32.32x set in Sep 2007, and 50% above its historical low of 2.04x in Dec 2008.
WallStSmart Analysis Synopsis
Data-driven financial summary for Simulations Plus Inc (SLP) · HEALTHCARE › HEALTH INFORMATION SERVICES
The Big Picture
Simulations Plus Inc is in a turnaround phase, with management focused on restoring profitability. Revenue reached 79M with 270% decline year-over-year. The company is currently unprofitable, posting a -81.7% profit margin.
Key Findings
Generating 4M in free cash flow and 4M in operating cash flow. Earnings are translating into actual cash generation.
Revenue contracted 270% YoY. Worth determining whether this is cyclical or structural.
The company is unprofitable with a -81.7% profit margin. The path to breakeven will be the key catalyst.
What to Watch Next
Sector dynamics: monitor HEALTH INFORMATION SERVICES industry trends, competitive moves, and regulatory changes that could impact Simulations Plus Inc.
Bottom Line
Simulations Plus Inc is in turnaround mode. The path to profitability remains the critical question. Speculative investors may see opportunity in the recovery story, but conservative investors should wait for consistent positive earnings before committing capital.
This synopsis is generated from publicly available financial data. It is not financial advice. Always conduct your own research and consult a qualified financial advisor before making investment decisions.
Insider Transactions(8 last 3 months)
Data sourced from SEC Form 4 filings
Last updated: 8:21:22 AM
About Simulations Plus Inc(SLP)
NASDAQ
HEALTHCARE
HEALTH INFORMATION SERVICES
USA
Simulations Plus, Inc. develops drug discovery and development software for mechanistic modeling, simulation, and prediction of molecule properties using artificial intelligence and machine learning technology worldwide. The company is headquartered in Lancaster, California.